These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23235194)

  • 1. Acute and subchronic toxicity evaluation of poly(ε-caprolactone) lipid-core nanocapsules in rats.
    Bulcão RP; Freitas FA; Venturini CG; Dallegrave E; Durgante J; Göethel G; Cerski CT; Zielinsky P; Pohlmann AR; Guterres SS; Garcia SC
    Toxicol Sci; 2013 Mar; 132(1):162-76. PubMed ID: 23235194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo toxicological evaluation of polymeric nanocapsules after intradermal administration.
    Bulcão RP; de Freitas FA; Dallegrave E; Venturini CG; Baierle M; Durgante J; Sauer E; Cassini C; Cerski CT; Zielinsky P; Salvador M; Pohlmann AR; Guterres SS; Garcia SC
    Eur J Pharm Biopharm; 2014 Feb; 86(2):167-77. PubMed ID: 23643792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute toxicity evaluation of in situ gel-forming controlled drug delivery system based on biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer.
    Fang F; Gong CY; Dong PW; Fu SZ; Gu YC; Guo G; Zhao X; Wei YQ; Qian ZY
    Biomed Mater; 2009 Apr; 4(2):025002. PubMed ID: 19208940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin-loaded poly(ϵ-caprolactone) lipid-core nanocapsules: Evaluation of fetal and maternal toxicity.
    Giacomeli R; Guerra Teixeira FE; Carvalho FB; Pacheco CO; Martins Parisotto AJ; Funguetto Ribeiro AC; Gomes de Gomes M; Haas SE
    Food Chem Toxicol; 2020 Oct; 144():111625. PubMed ID: 32738367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemocompatibility of poly(ɛ-caprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan.
    Bender EA; Adorne MD; Colomé LM; Abdalla DSP; Guterres SS; Pohlmann AR
    Int J Pharm; 2012 Apr; 426(1-2):271-279. PubMed ID: 22322210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of Isotonic, Sterile, and Kinetically Stable Lipid-Core Nanocapsules for Injectable Administration.
    Paese K; Ortiz M; Frank LA; Külkamp-Guerreiro IC; Rolim CM; Barros DM; Pohlmann AR; Guterres SS
    AAPS PharmSciTech; 2017 Jan; 18(1):212-223. PubMed ID: 26956145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivatives.
    Najlaoui F; Pigeon P; Aroui S; Pezet M; Sancey L; Marrakchi N; Rhouma A; Jaouen G; De Waard M; Busser B; Gibaud S
    J Pharm Pharmacol; 2018 Nov; 70(11):1474-1484. PubMed ID: 30141195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric versus lipid nanocapsules for miconazole nitrate enhanced topical delivery:
    Abdel-Rashid RS; Helal DA; Alaa-Eldin AA; Abdel-Monem R
    Drug Deliv; 2022 Dec; 29(1):294-304. PubMed ID: 35037528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
    Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
    J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel therapeutic mechanisms determine the effectiveness of lipid-core nanocapsules on melanoma models.
    Drewes CC; Fiel LA; Bexiga CG; Asbahr AC; Uchiyama MK; Cogliati B; Araki K; Guterres SS; Pohlmann AR; Farsky SP
    Int J Nanomedicine; 2016; 11():1261-79. PubMed ID: 27099491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subchronic intravenous toxicity studies with gamma-cyclodextrin in rats.
    Donaubauer HH; Fuchs H; Langer KH; Bär A
    Regul Toxicol Pharmacol; 1998 Apr; 27(2):189-98. PubMed ID: 9671574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment.
    Zanotto-Filho A; Coradini K; Braganhol E; Schröder R; de Oliveira CM; Simões-Pires A; Battastini AM; Pohlmann AR; Guterres SS; Forcelini CM; Beck RC; Moreira JC
    Eur J Pharm Biopharm; 2013 Feb; 83(2):156-67. PubMed ID: 23219677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inner ear biocompatibility of lipid nanocapsules after round window membrane application.
    Zhang Y; Zhang W; Löbler M; Schmitz KP; Saulnier P; Perrier T; Pyykkö I; Zou J
    Int J Pharm; 2011 Feb; 404(1-2):211-9. PubMed ID: 21075187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A subchronic toxicity study of Rokanol B-2 in rats.
    Krysiak B; Rydzyński K; Stetkiewicz J; Stetkiewicz I
    Int J Occup Med Environ Health; 1996; 9(4):351-64. PubMed ID: 9117194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subchronic toxicity and immunotoxicity of MeO-PEG-poly(D,L-lactic-co-glycolic acid)-PEG-OMe triblock copolymer nanoparticles delivered intravenously into rats.
    Liao L; Zhang M; Liu H; Zhang X; Xie Z; Zhang Z; Gong T; Sun X
    Nanotechnology; 2014 Jun; 25(24):245705. PubMed ID: 24869981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety assessment of a solid lipid curcumin particle preparation: acute and subchronic toxicity studies.
    Dadhaniya P; Patel C; Muchhara J; Bhadja N; Mathuria N; Vachhani K; Soni MG
    Food Chem Toxicol; 2011 Aug; 49(8):1834-42. PubMed ID: 21571027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(ε-caprolactone)nanocapsules as carrier systems for herbicides: physico-chemical characterization and genotoxicity evaluation.
    Grillo R; dos Santos NZ; Maruyama CR; Rosa AH; de Lima R; Fraceto LF
    J Hazard Mater; 2012 Sep; 231-232():1-9. PubMed ID: 22795586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous delivery of furosemide using lipid-based versus polymer-based nanocapsules:
    Kamel YN; El-Marakby EM; Gad HA
    Pharm Dev Technol; 2024 Sep; 29(7):738-750. PubMed ID: 39105766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats.
    Damgé C; Maincent P; Ubrich N
    J Control Release; 2007 Feb; 117(2):163-70. PubMed ID: 17141909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface modification of lipid nanocapsules with polysaccharides: from physicochemical characteristics to in vivo aspects.
    Hirsjärvi S; Dufort S; Bastiat G; Saulnier P; Passirani C; Coll JL; Benoît JP
    Acta Biomater; 2013 May; 9(5):6686-93. PubMed ID: 23395817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.